HOCHDORF Holding AG

EQS-Adhoc: HOCHDORF Holding AG: Press release on the extraordinary General Meeting on 29/11/2016


EQS Group-Ad-hoc: HOCHDORF Holding AG / Key word(s): AGM/EGM
HOCHDORF Holding AG: Press release on the extraordinary General Meeting on
29/11/2016

30.11.2016 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.


--------------------------------------------------------------------------------
Press release on the HOCHDORF Group Extraordinary General Meeting on 29/11/2016

HOCHDORF moving towards the end user

Hochdorf, 30 November 2016 -The 204 shareholders attending the Extraordinary
General Meeting for HOCHDORF Holding Ltd accepted the proposals submitted by the
Board of Directors. They approved the request for a conditional capital increase
and an increase in the registering and voting restriction from 5% to 15%. With
this decision, the shareholders have paved the way towards a majority holding in
the Pharmalys Group. The election of Michiel de Ruiter to the Board of Directors
was also approved by a clear majority of shareholders.

The Extraordinary General Meeting was led by Josef Leu, Chairman of the Board of
Directors of HOCHDORF Holding Ltd, with 204 shareholders in attendance
representing a total of 745,411 share votes (79.83 per cent of the share votes).

Dr Thomas Eisenring, CEO, explained the transaction at the Extraordinary General
Meeting and provided information on various details relating to the
implementation of the majority holding of the Pharmalys companies. Mr Eisenring
outlined the consolidated balance sheet and income statement for both the
HOCHDORF Group and Pharmalys Laboratories SA. The CEO also referred to the great
synergy potential and mentioned some aspects that would minimise risk. Marcel
Gavillet, CFO, outlined details for implementing the planned capital increase.
The compulsory convertible bond will be paid up on 31.3.2017.

Statute changes approved
Both the conditional capital increase and the increase to the registering and
voting restriction from 5% to 15% were approved by the shareholders by a
substantial majority. This vote supports the HOCHDORF Group's move towards the
end user and its majority holding in Pharmalys Laboratories SA, Pharmalys
Tunisia SA and the new joint venture, Pharmalys Africa Sarl. Chairman of the
Board of Directors, Josef Leu, was delighted by the approval and the confidence
in the company's direction that it represents.

Michiel de Ruiter's election as additional board member
The election of Michiel de Ruiter as an additional member of the Board of
Directors for HOCHDORF Holding Ltd has also met with approval. De Ruiter is a
proven expert in the area of infant formula and his expertise is a welcome
addition to the board.

The presentation to the shareholders' meeting is available on theHOCHDORF Group
website.



Voting results in detail

Agenda item 1 Conditional capital increase
The General Meeting approved the conditional capital increase by 728,283 votes
(97.5% of the shareholder votes cast).

Agenda item 2 Increase in the registering and voting restrictions from 5% to 15%
The General Meeting approved the increase in the registering and voting
restrictions from 5% to 15% by 691,373 votes (94.2% of the shareholder votes
cast).

Agenda item 3 Michiel de Ruiter's election as additional board member
The shareholders elected Michiel de Ruiter onto the Board of Directors by
742,764 votes (99.6%). He was elected up to and including the Annual General
Meeting of 2017.

Additional features:


Document:http://n.eqs.com/c/fncls.ssp?u=VXAPYUFTNK
Document title: Press Release on the HOCHDORF Group extraordinary General
Meeting

--------------------------------------------------------------------------------
End of ad hoc announcement------------------------------------------------------
Information and Explanation of the Issuer to this News:


In 2015 the HOCHDORF Group, which is headquartered in Hochdorf, generated a
consolidated gross sales revenue of CHF 551.2 million. It is one of the leading
foodstuff companies in Switzerland, with more than 625 employees as at 31
December 2015. Made from such natural ingredients as milk, wheat germ, and
oilseeds, HOCHDORF products have been contributing to the health and well-being
of the young and old alike since 1895. Our customers include the food industry
and wholesalers and retailers. Our products are sold in more than 90 countries.
HOCHDORF stock is traded on the SIX Swiss Exchange in Zurich (ISIN
CH0024666528).


--------------------------------------------------------------------------------

Language: English

Company:  HOCHDORF Holding AG

          Siedereistrasse 9

          6281 Hochdorf

          Switzerland

Phone:    +41 41 914 65 65

Fax:      +41 41 914 66 66

E-mail:hochdorf@hochdorf.com

Internet: www.hochdorf.com

ISIN:     CH0024666528

Listed:   SIX Swiss Exchange


End of News EQS Group News Service
--------------------------------------------------------------------------------
525323  30.11.2016 
 

 


Weitere Meldungen: HOCHDORF Holding AG

Das könnte Sie auch interessieren: